about
Quality of life in HIV clinical trials: why sexual health must not be ignored.Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults.Simplified tools for measuring retention in care in antiretroviral treatment program in Ethiopia: cohort and current retention in care.Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo.Short and long term retention in antiretroviral care in health facilities in rural Malawi and ZimbabweImpact of changing diagnostic criteria for smear-positive tuberculosis: a cohort study in Malawi.Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005-2012.Bloodstream infection among adults in Phnom Penh, Cambodia: key pathogens and resistance patterns.Evaluation of the 2007 WHO guideline to diagnose smear negative tuberculosis in an urban hospital in Ethiopia.Melioidosis, phnom penh, Cambodia.Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.Determinants of male involvement in maternal and child health services in sub-Saharan Africa: a review.Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia.Incidence of HCV and sexually transmitted diseases among hiv positive msm in antwerp, belgium, 2001-2011.Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection.Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique.Health Outcomes of Infants in a PMTCT Program in Kinshasa.Reducing mortality from HIV infection and tuberculosis.ART in low-resource settings: how to do more with less.An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia.Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers, 1994 to 2006.Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort.Validation of a clinical prediction score to target viral load testing in adults with suspected first-line treatment failure in resource-constrained settings.Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial.Universal access to HIV care: pitfalls and the way forwardTuberculosis Screening and Diagnosis in People with HIVDetermination of Kidney Function Before Tenofovir Initiation: Four-Fold Difference in Need of Tenofovir Dose Reduction Depending on Method UsedIncidence and risk factors associated with lost to follow-up in a Belgian cohort of HIV-infected patients treated with highly active antiretroviral therapy“Absolute” or “added” predictive value?Self-reported disability in rural Malawi: prevalence, incidence, and relationship to chronic diseasePrimary healthcare and school health service utilisation by adolescents and young adults in KwaZulu-Natal, South Africa
P50
Q33276414-97F798EC-472F-4599-A63A-C101A3DF705BQ33659242-42098272-EE12-4B70-96BE-2BEBE98A2C1AQ33873792-863F6ABE-9266-4261-8292-DDC4B33B9F2EQ34305515-4743BB44-BD3C-4462-81B9-A4D3B43F8AD4Q34345476-E7C80F62-3A8B-41EE-BBBB-82E169AF6EBBQ34502586-FFBBCEB9-A3FF-47EE-9663-044C57D98735Q34546715-DE757283-EA78-42EC-BF80-A097F77FE738Q34559026-D487909A-FBB3-4FE2-9A8F-4359154E1EDEQ34652195-708D996F-E77D-49BF-991D-E0C28FA480C4Q34983114-8E8A4916-0F27-4870-B8C9-DEC499FDFA0CQ36053145-0E6BA1B8-2BD3-4D01-BC1F-2FD303388E85Q36495608-FC19B395-5C95-421E-828D-01EFBBFDF4C9Q36614235-EA0686A2-25AF-4598-A601-8E0441AB8F1BQ37080209-19A44389-7B1A-407B-A2E3-BEC867049CF5Q37554466-33BD6067-0524-46ED-89FE-CD4F5FA649A1Q37844713-55364255-F753-4F32-8FCE-B0F7899825A7Q38868050-BAC2C23E-A3FA-4AFA-AEC0-6DD2EA885EA0Q38869273-6B869CA3-43F7-4516-8DD6-E3F9D2B045ACQ38968263-466C96B5-290D-4A90-991C-370D7E86D5A2Q38974062-1D40A2B5-7CBA-463F-8A32-84C45DDC9831Q39145038-6810B4DE-BC39-498E-8638-E261D10B0F3EQ39145048-F7268E25-5ECE-4558-ADC3-815A36BC1478Q39196161-ED15AB7A-0A73-4B46-9910-D3E73CC49C88Q39563691-BB4AB416-36F5-42EB-8F7A-412138A74BA0Q39633288-BFDD7DD2-2466-4CA2-BE55-8E51FAEC1B09Q42278072-243E591E-97FB-4697-AE20-841CD274E28EQ45030714-FFFA4201-504B-45E0-A4C4-24A8FBEE0324Q45352254-453F8057-0C20-41C5-B75B-AAB885AAB510Q57078158-1F508DAC-CC87-435A-ABF8-6AEA14A123C1Q57556231-FE8819F2-F530-4DB2-B6D7-2CB38CEF5316Q58293428-9C25396B-D4F9-4E20-B494-13E8209391AEQ58862413-8ED1293F-86AD-40D5-9DFE-7928E31330CFQ61819572-AD4AF3BA-E1FB-4090-B5F2-56C3AF4B53EBQ72432777-6735260B-BECA-4CC5-B78D-3FACFDAA9C45Q91518162-D9F1068E-CB82-4FF2-9889-30AFE33BEBE9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Olivier Koole
@ast
Olivier Koole
@en
Olivier Koole
@es
Olivier Koole
@nl
Olivier Koole
@sl
type
label
Olivier Koole
@ast
Olivier Koole
@en
Olivier Koole
@es
Olivier Koole
@nl
Olivier Koole
@sl
prefLabel
Olivier Koole
@ast
Olivier Koole
@en
Olivier Koole
@es
Olivier Koole
@nl
Olivier Koole
@sl
P106
P21
P31
P496
0000-0002-1122-5382